Cortical neurons develop insulin resistance and blunted Akt signaling: A potential mechanism contributing to enhanced ischemic injury in diabetes

Antioxidants and Redox Signaling

Volumn 14, Issue 10, 2011, Pages 1829-1839

  Kim, Bhumsoo ^a   Sullivan, Kelli A ^a   Backus, Carey ^a   Feldman, Eva L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PALMITIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CELL; DIABETES MELLITUS; EMBRYO; HYPERINSULINEMIA; INSULIN RESISTANCE; ISCHEMIA; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; BUTADIENES; CELLS, CULTURED; CEREBRAL CORTEX; CHROMONES; ENZYME INHIBITORS; FEMALE; GLYCOGEN SYNTHASE KINASE 3; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MORPHOLINES; NEURONS; NITRILES; PHOSPHORYLATION; PREGNANCY; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION;

MUS;

EID: 79954620946     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3816     Document Type: Article

References (71)

1. Abbott RD, Donahue RP, MacMahon SW, Reed DM, and Yano K. Diabetes and the risk of stroke. The Honolulu Heart Program. JAMA 257: 949-952, 1987. (Pubitemid 17024388)
2. Abe T, Takagi N, Nakano M, Furuya M, and Takeo S. Altered Bad localization and interaction between Bad and BclxL in the hippocampus after transient global ischemia. Brain Res 1009: 159-168, 2004. (Pubitemid 38553858)
3. Aberg D. Role of the growth hormone/insulin-like growth factor 1 axis in neurogenesis. Endocr Dev 17: 63-76, 2010.
4. Allen CL and Bayraktutan U. Risk factors for ischaemic stroke. Int J Stroke 3: 105-116, 2008. (Pubitemid 351566844)
5. Belfiore A, Frasca F, Pandini G, Sciacca L, and Vigneri R. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev 30: 586-623, 2009.
6. Bravata DM, Wells CK, Kernan WN, Concato J, Brass LM, and Gulanski BI. Association between impaired insulin sensitivity and stroke. Neuroepidemiology 25: 69-74, 2005. (Pubitemid 41022607)
7. Bruce KD and Hanson MA. The developmental origins, mechanisms, and implications of metabolic syndrome. J Nutr 140: 648-652, 2010.
8. Burgos-Ramos E, Chowen JA, Argente J, and Barrios V. Regional and temporal differences in leptin signaling in rat brain. Gen Comp Endocrinol 167: 143-152, 2010.
9. Carloni S, Girelli S, Buonocore G, Longini M, and Balduini W. Simvastatin acutely reduces ischemic brain damage in the immature rat via Akt and CREB activation. Exp Neurol 220: 82-89, 2009.
10. Carpentier JL. Insulin receptor internalization: molecular mechanisms and physiopathological implications. Diabetologia 37 Suppl 2: S117-S124, 1994.
11. Craft S, Asthana S, Newcomer JW, Wilkinson CW, Matos IT, Baker LD, Cherrier M, Lofgreen C, Latendresse S, Petrova A, Plymate S, Raskind M, Grimwood K, and Veith RC. Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch Gen Psychiatry 56: 1135-1140, 1999.
12. Craft S and Watson GS. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 3: 169-178, 2004. (Pubitemid 38229951)
13. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, and Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241, 1997. (Pubitemid 27456390)
14. Duarte AI, Santos P, Oliveira CR, Santos MS, and Rego AC. Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3beta signaling pathways and changes in protein expression. Biochim Biophys Acta 1783: 994-1002, 2008.
15. Duarte JM, Morgenthaler FD, Lei H, Poitry-Yamate C, and Gruetter R. Steady-state brain glucose transport kinetics reevaluated with a four-state conformational model. Front Neuroenergetics 1: 6, 2009.
16. Edwards JL, Vincent AM, Cheng HT, and Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Ther 120: 1-34, 2008.
17. Endo H, Nito C, Kamada H, Nishi T, and Chan PH. Activation of the Akt/GSK3beta signaling pathway mediates survival of vulnerable hippocampal neurons after transient global cerebral ischemia in rats. J Cereb Blood Flow Metab 26: 1479-1489, 2006. (Pubitemid 44809077)
18. Folsom AR, Rasmussen ML, Chambless LE, Howard G, Cooper LS, Schmidt MI, and Heiss G. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care 22: 1077-1083, 1999. (Pubitemid 29293959)
19. Fuenzalida K, Quintanilla R, Ramos P, Piderit D, Fuentealba RA, Martinez G, Inestrosa NC, and Bronfman M. Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis. J Biol Chem 282: 37006-37015, 2007.
20. Fukunaga K and Kawano T. Akt is a molecular target for signal transduction therapy in brain ischemic insult. J Pharmacol Sci 92: 317-327, 2003. (Pubitemid 37098256)
21. Group UPDS. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 854-865, 1998.
22. Hamblin M, Chang L, Fan Y, Zhang J, and Chen YE. PPARs and the cardiovascular system. Antioxid Redox Signal 11: 1415-1452, 2009.
23. Harmsen P, Rosengren A, Tsipogianni A, and Wilhelmsen L. Risk factors for stroke in middle-aged men in Goteborg, Sweden. Stroke 21: 223-229, 1990. (Pubitemid 20067923)
24. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, and Tejada-Vera B. Deaths: final data for 2006. Natl Vital Stat Rep 57: 1-134, 2009.
25. Hishinuma A, Majima M, and Kurabayashi H. Is insulin resistance related to recurrence of stroke or incident of ischemic heart disease in patients with stroke? A preliminary report. J Stroke Cerebrovasc Dis 18: 294-297, 2009.
26. Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z, Peng Y, Cambareri G, Rocher A, Mobbs CV, Hof PR, and Pasinetti GM. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J 18: 902-904, 2004.
27. Hu G, Jousilahti P, Sarti C, Antikainen R, and Tuomilehto J. The effect of diabetes and stroke at baseline and during follow-up on stroke mortality. Diabetologia 49: 2309-2316, 2006. (Pubitemid 44359091)
28. Hu H, Yamashita S, Hua Y, Keep RF, Liu W, and Xi G. Thrombin-induced neuronal protection: role of the mitogen activated protein kinase/ribosomal protein S6 kinase pathway. Brain Res 1361: 93-101, 2010.
29. Janelidze S, Hu BR, Siesjo P, and Siesjo BK. Alterations of Akt1 (PKBalpha) and p70(S6K) in transient focal ischemia. Neurobiol Dis 8: 147-154, 2001. (Pubitemid 32171826)
30. Kawano T, Fukunaga K, Takeuchi Y, Morioka M, Yano S, Hamada J, Ushio Y, and Miyamoto E. Neuroprotective effect of sodium orthovanadate on delayed neuronal death after transient forebrain ischemia in gerbil hippocampus. J Cereb Blood Flow Metab 21: 1268-1280, 2001. (Pubitemid 33130939)
31. Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, and Horwitz RI. Insulin resistance and risk for stroke. Neurology 59: 809-815, 2002.
32. Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Shulman GI, McVeety JC, and Horwitz RI. Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke. Neurology 60: 1447-1451, 2003. (Pubitemid 36554804)
33. Kim B, Backus C, Oh S, Hayes JM, and Feldman EL. Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. Endocrinology 150: 5294-5301, 2009.
34. Kim SJ and Kahn CR. Insulin stimulates p70 S6 kinase in the nucleus of cells. Biochem Biophys Res Commun 234: 681-685, 1997. (Pubitemid 27281179)
35. Koh SH, Yoo AR, Chang DI, Hwang SJ, and Kim SH. Inhibition of GSK-3 reduces infarct volume and improves neurobehavioral functions. Biochem Biophys Res Commun 371: 894-899, 2008.
36. Laws A, Marcus EB, Grove JS, and Curb JD. Lipids and lipoproteins as risk factors for coronary heart disease in men with abnormal glucose tolerance: the Honolulu Heart Program. J Intern Med 234: 471-478, 1993. (Pubitemid 23343351)
37. Lehto S, Ronnemaa T, Pyorala K, and Laakso M. Predictors of stroke in middle-aged patients with non-insulindependent diabetes. Stroke 27: 63-68, 1996. (Pubitemid 26008297)
38. Leinninger GM, Backus C, Sastry AM, Yi YB, Wang CW, and Feldman EL. Mitochondria in DRG neurons undergo hyperglycemic mediated injury through Bim, Bax and the fission protein Drp1. Neurobiol Dis 23: 11-22, 2006. (Pubitemid 44192383)
39. Liu C, Wu J, Xu K, Cai F, Gu J, Ma L, and Chen J. Neuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway. J Neurochem 112: 1500-1512, 2010.
40. Liu HY, Cao SY, Hong T, Han J, Liu Z, and Cao W. Insulin is a stronger inducer of insulin resistance than hyperglycemia in mice with type 1 diabetes mellitus (T1DM). J Biol Chem 284: 27090-27100, 2009.
41. Liu HY, Hong T, Wen GB, Han J, Zuo D, Liu Z, and Cao W. Increased basal level of Akt-dependent insulin signaling may be responsible for the development of insulin resistance. Am J Physiol Endocrinol Metab 297: E898-E906, 2009.
42. Mayfield J. Diagnosis and classification of diabetes mellitus: new criteria. Am Fam Physician 58: 1355-1362, 1369-1370, 1998. (Pubitemid 28489336)
43. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, and Heiss G. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28: 385-390, 2005. (Pubitemid 40170944)
44. Meeuwisse-Pasterkamp SH, van der Klauw MM, and Wolffenbuttel BH. Type 2 diabetes mellitus: prevention of macrovascular complications. Expert Rev Cardiovasc Ther 6: 323-341, 2008.
45. Myint PK, Sinha S, Wareham NJ, Bingham SA, Luben RN, Welch AA, and Khaw KT. Glycated hemoglobin and risk of stroke in people without known diabetes in the European Prospective Investigation into Cancer (EPIC)-Norfolk prospective population study: a threshold relationship? Stroke 38: 271-275, 2007. (Pubitemid 46184293)
46. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, and Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 109: 42-46, 2004. (Pubitemid 38056019)
47. Ouyang YB, Tan Y, Comb M, Liu CL, Martone ME, Siesjo BK, and Hu BR. Survival-and death-promoting events after transient cerebral ischemia: phosphorylation of Akt, release of cytochrome C and Activation of caspase-like proteases. J Cereb Blood Flow Metab 19: 1126-1135, 1999. (Pubitemid 30167763)
48. Pyorala M, Miettinen H, Laakso M, and Pyorala K. Hyperinsulinemia and the risk of stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Stroke 29: 1860-1866, 1998. (Pubitemid 28399978)
49. Quinn TJ and Lees KR. Hyperglycaemia in acute stroke-to treat or not to treat. Cerebrovasc Dis 27 Suppl 1: 148-155, 2009.
50. Rena G, Guo S, Cichy SC, Unterman TG, and Cohen P. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J Biol Chem 274: 17179-17183, 1999.
51. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, and Feldman EL. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 6: 347-363, 1999. (Pubitemid 29496214)
52. Sanderson TH, Kumar R, Murariu-Dobrin AC, Page AB, Krause GS, and Sullivan JM. Insulin activates the PI3K-Akt survival pathway in vulnerable neurons following global brain ischemia. Neurol Res 31: 947-958, 2009.
53. Schubert M, Gautam D, Surjo D, Ueki K, Baudler S, Schubert D, Kondo T, Alber J, Galldiks N, Kustermann E, Arndt S, Jacobs AH, Krone W, Kahn CR, and Bruning JC. Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci USA 101: 3100-3105, 2004. (Pubitemid 38327741)
54. Shahar E, Chambless LE, Rosamond WD, Boland LL, Ballantyne CM, McGovern PG, and Sharrett AR. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 34: 623-631, 2003. (Pubitemid 36307382)
55. Shimazu T, Inoue I, Araki N, Asano Y, Sawada M, Furuya D, Nagoya H, and Greenberg JH. A peroxisome proliferatoractivated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia. Stroke 36: 353-359, 2005. (Pubitemid 40170822)
56. Shioda N, Ishigami T, Han F, Moriguchi S, Shibuya M, Iwabuchi Y, and Fukunaga K. Activation of phosphatidylinositol 3-kinase/protein kinase B pathway by a vanadyl compound mediates its neuroprotective effect in mouse brain ischemia. Neuroscience 148: 221-229, 2007. (Pubitemid 47211622)
57. Silver IA and Erecinska M. Extracellular glucose concentration in mammalian brain: continuous monitoring of changes during increased neuronal activity and upon limitation in oxygen supply in normo, hypo, and hyperglycemic animals. J Neurosci 14: 5068-5076, 1994.
58. Sullivan KA, Lentz SI, Roberts JL Jr., and Feldman EL. Criteria for creating and assessing mouse models of diabetic neuropathy. Curr Drug Targets 9: 3-13, 2008. (Pubitemid 351201677)
59. Sundararajan S, Gamboa JL, Victor NA, Wanderi EW, Lust WD, and Landreth GE. Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience 130: 685-696, 2005. (Pubitemid 39601441)
60. Vannucci SJ, Willing LB, Goto S, Alkayed NJ, Brucklacher RM, Wood TL, Towfighi J, Hurn PD, and Simpson IA. Experimental stroke in the female diabetic, db/db, mouse. J Cereb Blood Flow Metab 21: 52-60, 2001. (Pubitemid 32016839)
61. Vincent AM, Hinder LM, Pop-Busui R, and Feldman EL. Hyperlipidemia: a new therapeutic target for diabetic neuropathy. J Peripher Nerv Syst 14: 257-267, 2009.
62. Vincent AM, McLean LL, Backus C, and Feldman EL. Shortterm hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J 19: 638-640, 2005. (Pubitemid 40471270)
63. Wada A. GSK-3 inhibitors and insulin receptor signaling in health, disease, and therapeutics. Front Biosci 14: 1558-1570, 2009.
64. Wada A, Yokoo H, Yanagita T, and Kobayashi H. Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases. J Pharmacol Sci 99: 307-321, 2005. (Pubitemid 41813422)
65. West DB, Boozer CN, Moody DL, and Atkinson RL. Dietary obesity in nine inbred mouse strains. Am J Physiol 262: R1025-R1032, 1992.
66. Xu QG, Li XQ, Kotecha SA, Cheng C, Sun HS, and Zochodne DW. Insulin as an in vivo growth factor. Exp Neurol 188: 43-51, 2004. (Pubitemid 38748803)
67. Xu X, Chua CC, Gao J, Chua KW, Wang H, Hamdy RC, and Chua BH. Neuroprotective effect of humanin on cerebral ischemia/reperfusion injury is mediated by a PI3K/Akt pathway. Brain Res 1227: 12-18, 2008.
68. Yue Tl TL, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, Lysko PG, Gu JL, Boyce R, Zimmerman DM, Hart TK, Buckingham RE, and Ohlstein EH. In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 104: 2588-2594, 2001. (Pubitemid 33104798)
69. Zhang F and Chen J. Leptin protects hippocampal CA1 neurons against ischemic injury. J Neurochem 107: 578-587, 2008.
70. Zhang T, Pan BS, Sun GC, Sun X, and Sun FY. Diabetes synergistically exacerbates poststroke dementia and tau abnormality in brain. Neurochem Int 56: 955-961, 2010.
71. Zhao H, Sapolsky RM, and Steinberg GK. Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol 34: 249-270, 2006.